Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 67
Filtrar
1.
Pediatr Dermatol ; 29(4): 525-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21854420

RESUMO

We report a new case of postvaccination morphea profunda (MP) in a child and discuss its different clinical presentations, prognosis, and therapy and its relationship with "solitary morphea profunda." A 2-year-old healthy girl presented with an induration of the anterior aspect of the left thigh of 9 months duration. The lesion had appeared 3 months after a third dose of diphtheria-tetanus-pertussis vaccine. Cutaneous examination showed an induration of 7 × 7 cm with an "orange peel" texture after pinching the skin. Histologic examination confirmed the diagnosis of MP. Systemic steroids (1 mg/kg/day) led to the stabilization of the lesion. After 4 months of treatment, we began the concomitant use of oral methotrexate (10 mg/wk) for 2 months. Methotrexate was then continued alone for 10 months, leading to a significant regression of the induration with no relapse.


Assuntos
Vacina contra Difteria, Tétano e Coqueluche/administração & dosagem , Vacina contra Difteria, Tétano e Coqueluche/efeitos adversos , Esclerodermia Localizada/etiologia , Coxa da Perna , Antimetabólitos Antineoplásicos/uso terapêutico , Pré-Escolar , Feminino , Humanos , Injeções Intramusculares , Metotrexato/uso terapêutico , Esclerodermia Localizada/tratamento farmacológico , Esclerodermia Localizada/patologia , Esteroides/uso terapêutico
2.
Tunis Med ; 90(1): 45-50, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22311448

RESUMO

BACKGROUND: Cutaneous adverse drug reactions (CADR) are frequent in children. They have different clinical presentations and may be caused by several drugs. AIM: To evaluate the epidemioclinical features of cutaneous adverse drug reactions (CADR) and the different causative drugs in a Tunisian paediatric series. METHODS: We have retrospectively included 90 children (under 16 years old) with a well documented cutaneous drug reaction, seen in the Department of Dermatology of Charles Nicolle hospital of Tunis over 18 years (1991-2008). Age, gender, duration of skin disorders, type of cutaneous lesions, incriminated drugs, delay between drug consumption and eruption, validation by the national pharmacovigilance centre, treatment and outcome were recorded. RESULTS: Our patients were 6.9 year-aged (sex-ratio M/F 1.19). They had maculopapular eruption (MPE) (57.7%), acute urticaria (16.6%), fixed drug eruption (14.4%), erythema multiform (2.2%), photosensitization (1.1%) or severe cutaneous drug reactions (10%).Incriminated drugs were: Antibiotics (55.5%), non-steroidal antiinflammatory drugs (18.8%), antiepileptics (11.1%), and analgesics (5.5%). Betalactamins were the most commonly incriminated antibiotics (32 out of 50 patients; 64%). Barbiturates were the most commonly incriminated anti-epileptics (7/90 cases, 7.7%). Favourable outcome was noted in all patients, even those with severe drug reactions. CONCLUSION: MPE to antibiotics were the most common kinds of CADR in children. Drug responsibility should be based on solid criteria given the frequency of MPE of infectious origin and the frequent prescription of antibiotics in paediatric population.


Assuntos
Toxidermias/epidemiologia , Toxidermias/patologia , Adolescente , Analgésicos/efeitos adversos , Antibacterianos/efeitos adversos , Anti-Inflamatórios não Esteroides/efeitos adversos , Anticonvulsivantes/efeitos adversos , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Estudos Retrospectivos , Tunísia/epidemiologia
3.
Therapie ; 66(5): 453-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22031690

RESUMO

BACKGROUND: Chronic actinic dermatitis (CAD) is a debilitating photodermatosis with characteristic clinical, histological and photobiological features (reduced minimal erythema dose: MED). Its management involves various therapeutic approaches, among them there is phototherapy. Efficacy of psoralen ultraviolet therapy (PUVA therapy) was previously demonstrated but there are no current data on the use of narrowband ultra violet B (UVB) therapy (NB-UVB) in CAD. NB-UVB has already been proven to be effective and safe in several other photodermatoses. CASE REPORTS: We report here two dark-skinned patients (skin type IV and V) with CAD, successfully treated with an incremental regimen of NB-UVB phototherapy coupled to a 3 month-course of systemic steroids (1mg/Kg/day). CONCLUSION: Our protocol of NB-UVB with steroids seems to be effective for the management of CAD with a good short term safety profile.


Assuntos
Anti-Inflamatórios/uso terapêutico , Terapia PUVA/métodos , Transtornos de Fotossensibilidade/terapia , Esteroides/uso terapêutico , Idoso , Doenças dos Trabalhadores Agrícolas , Humanos , Masculino , Pessoa de Meia-Idade , Exposição Ocupacional , Terapia PUVA/efeitos adversos , Transtornos de Fotossensibilidade/tratamento farmacológico , Transtornos de Fotossensibilidade/radioterapia , Prednisona/uso terapêutico , Pele/patologia
4.
Ann Pathol ; 31(4): 246-50, 2011 Aug.
Artigo em Francês | MEDLINE | ID: mdl-21839347

RESUMO

INTRODUCTION: Kindler's syndrome is a rare type of genetic skin condition belonging to the class of bullous poikilodermia. We report three new sibling cases of this rare syndrome. CASES REPORTS: The condition was seen in three sisters aged 12, 16 and 20 years, born of a first-degree consanguineous marriage with no family history of Kindler's syndrome. The three patients presented spontaneously regressive bullous eruptions, poikilodermia of gradual onset, major cutaneous atrophy on the back of the hands and the feet, photosensitivity and gingival hypertrophy. Electron microscopy examination of poikilodermic skin showed normal anchoring filaments and intraepidermal cleavage. DISCUSSION: Diagnosis of Kindler's syndrome is based upon clinical evidence. Kidler's syndrome is a well defined clinical entity. Ultra-structural studies show intraepidermal, junctional, and dermal cleavage. This syndrome must be differentiated from congenital epidermolysis bullosa, Weary's syndrome, and other bullous hereditary poikilodermas.


Assuntos
Vesícula/patologia , Epidermólise Bolhosa/patologia , Doenças Periodontais/patologia , Transtornos de Fotossensibilidade/patologia , Adolescente , Vesícula/diagnóstico , Vesícula/epidemiologia , Vesícula/genética , Criança , Consanguinidade , Derme/ultraestrutura , Diagnóstico Diferencial , Epiderme/ultraestrutura , Epidermólise Bolhosa/diagnóstico , Epidermólise Bolhosa/epidemiologia , Epidermólise Bolhosa/genética , Feminino , Genes Recessivos , Humanos , Microscopia Eletrônica , Doenças Periodontais/diagnóstico , Doenças Periodontais/epidemiologia , Doenças Periodontais/genética , Transtornos de Fotossensibilidade/diagnóstico , Transtornos de Fotossensibilidade/epidemiologia , Transtornos de Fotossensibilidade/genética , Tunísia/epidemiologia , Adulto Jovem
5.
Dermatol Online J ; 17(7): 7, 2011 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-21810392

RESUMO

Erythema elevatum diutinum (EED) is a rare condition with an unclear pathogenesis. Initially classified within neutrophilic dermatoses, it is now considered as a leukocytoclastic vasculitis accordingly to its histopathologic pattern. Several clinical presentations as well as many associated diseases are reported in the literature. We report a new case of EED in a 58-year-old man who presented with a three-month history of plaques and nodules on the extensor surfaces of hands, elbows, knees, ankles, forearms, and buttocks. Histology showed a leucocytoclastic vasculitis, suggestive of the diagnosis of EED. Screening for an associated pathology, namely a paraproteinemia or a solid cancer, was negative. Treatment with dapsone leads to amelioration within few weeks.


Assuntos
Anti-Inflamatórios/uso terapêutico , Dapsona/uso terapêutico , Vasculite Leucocitoclástica Cutânea/tratamento farmacológico , Vasculite Leucocitoclástica Cutânea/patologia , Humanos , Masculino , Pessoa de Meia-Idade
6.
Tunis Med ; 89(1): 18-22, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21267822

RESUMO

AIM: To evaluate the epidemiological, clinical, biological features and prognostic factors in patients presenting an association of dermatomyositis (DM) and breast cancer (BC). METHODS: Medical records of 13 patients with DM and BC among 210 DM collected from January 1982 to march 2009 were retrospectively reviewed. RESULTS: Mean age was 47 ± 18 years. DM preceded BC in 3 patients, was concurrent with BC in 2 cases and followed it in 8 cases. Clinically, ulcerative and bullous lesions predominating on limbs were observed in 2 patients. A severe proximal muscular weakness was observed in 4 cases and one patient has presented an amyopathic dermatomyositis. BC was staged IV in 3 pts, IIIA in 2 cases while 3 had stage IIB, 3 stage IIA and 2 stage I according to TNM classification. Nine out of 13 patients had parallel improvement of DM symptoms after treatment of BC. Five patients died of recurrence or distant metastasis (mortality 41.66%). Median survival was 35 months (3-177) after DM diagnostic. CONCLUSION: In Tunisia, DM is associated with an increased incidence of BC. A paraneoplastic course of DM is noted in 70% of patients. In view of the increased risk of BC in our country, in addition to routine examination and laboratory screening, mammography, chest ultrasound, and gynaecological examination, are indicated in women with DM older than 40 years, particularly in case of previous personal or familial history of breast neoplasm.


Assuntos
Neoplasias da Mama/epidemiologia , Dermatomiosite/epidemiologia , Feminino , Humanos , Pessoa de Meia-Idade , Debilidade Muscular/epidemiologia , Síndromes Paraneoplásicas/epidemiologia , Estudos Retrospectivos , Tunísia/epidemiologia
7.
Tunis Med ; 89(3): 292-4, 2011 Mar.
Artigo em Francês | MEDLINE | ID: mdl-21387237

RESUMO

BACKGROUND: Hydroxyurea (HU) is an antineoplastic drug commonly used to treat chronic myeloproliferative disorders. Dermatological side effects are frequent and usually benign. Leg ulceration following HU therapy is less common. AIM: To describe epidemioclinical and therapeutic features of leg ulcers induced by HU. CASE REPORT: A 70-year-old woman is treated with hydroxyurea for polycythemia vera. One year later; she presented with a malleolar painful ulcer, initially healed without discontinuation of the treatment, but has been recurred 2 months later, becoming multiple and bilateral. HU has been discontinued and ulcers were completely cured. CONCLUSION: Leg ulcers induced by hydroxyurea are rare. Pathogenesis of HU-induced ulcers remains unknown and is multi factorial. Discontinuation of treatment is still the option of choice for complete recovery.


Assuntos
Antineoplásicos/efeitos adversos , Hidroxiureia/efeitos adversos , Úlcera da Perna/etiologia , Policitemia Vera/tratamento farmacológico , Idoso , Antineoplásicos/uso terapêutico , Feminino , Humanos , Hidroxiureia/uso terapêutico
8.
Tunis Med ; 89(6): 569-72, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21681723

RESUMO

BACKGROUND: Trichoblastoma is a rare and benign adnexial tumor with characteristic histological features. It occurs on any hair folliclebearing location, and usually presents as a solitary lesion most often less than 2 cm in size. Giant trichoblastoma has been rarely reported in the literature. AIM: To report a new case of giant trichoblastoma, misleading for malignancy. CASE REPORT: A 57-year-old woman presented with a 5 cm-solitary asymptomatic nodular lesion of the scalp, of 28 years. It had been previously excised with recurrence and progressive regrowth. On examination, it was a dome-shaped, erythematous, firm, papillomatous, non infiltrated nodule. Full body work up revealed no metastases. Cutaneous biopsy concluded to trichoblastoma but failed to eliminate malignancy. After excision with secondary skin graft, histological examination confirmed the benignity with clear margins. There was no evidence of recurrence after a 5 year-follow-up period. CONCLUSION: This case illustrates a rare clinical variant of trichoblastoma with an unusual important size. This can be misleading for malignancy, but the slowly progressive course of the tumour in our patient, together with histological benignity led to the correct diagnosis. This tumour is considered as a distinct entity by some authors.


Assuntos
Neoplasias de Cabeça e Pescoço/patologia , Couro Cabeludo , Neoplasias Cutâneas/patologia , Feminino , Humanos , Pessoa de Meia-Idade
9.
J Cutan Pathol ; 37(4): 452-9, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19719835

RESUMO

A unique feature of the skin immune system is its proximity to cells continuously exposed to sun rays, as it is located in the interface between the body and the environment. In this study, we aimed to determine the impact of DNA damaged keratinocytes on the expression of apoptotic-related molecules, in T-cells of the inflammatory component of the tumor environment. Immunohistochemistry was performed on tissue sections derived from skin biopsies of basal cell carcinomas (BCCs) of xeroderma pigmentosum (XP) patients, non-XP patients and nevoid basal cell carcinoma syndrome (NBCCS) patients, using antibodies against B-cell lymphoma/leukemia-2 (Bcl-2), Bcl-2 associated X protein (Bax), CD95, CD3, CD8 and CD56. Our results showed significantly lower levels of expression of the antiapoptotic Bcl-2 molecule, in XP, in comparison with non-XP and NBCCS T-lymphocytes, leading to the highest Bax/Bcl-2 ratio for XP T-cells. For the CD95 receptor expression levels, there were significant differences among T-cells of the three patient subgroups as well. The higher propensity of XP T-cells to undergo apoptosis may have evolved in individual XP patients, apparently during the course of their disease, to maintain a special skin as an immune privilege site for tumors' development.


Assuntos
Carcinoma Basocelular/metabolismo , Queratinócitos/metabolismo , Neoplasias Cutâneas/metabolismo , Pele/metabolismo , Xeroderma Pigmentoso/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos CD/metabolismo , Apoptose/imunologia , Síndrome do Nevo Basocelular/imunologia , Síndrome do Nevo Basocelular/metabolismo , Carcinoma Basocelular/imunologia , Sobrevivência Celular/genética , Criança , Feminino , Humanos , Imuno-Histoquímica , Queratinócitos/imunologia , Queratinócitos/patologia , Masculino , Pessoa de Meia-Idade , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Pele/imunologia , Pele/patologia , Neoplasias Cutâneas/imunologia , Neoplasias Cutâneas/patologia , Xeroderma Pigmentoso/imunologia , Xeroderma Pigmentoso/patologia , Proteína X Associada a bcl-2/metabolismo
10.
Pediatr Dermatol ; 27(2): 119-24, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20537062

RESUMO

Cicatricial pemphigoid is an extremely rare condition in children, since only 17 cases have been reported in the English literature, so far. We describe a new case in a 20-month-old boy, who is to our knowledge the youngest patient reported yet. The disorder had begun 10 months before he was referred to our department by mucosal crusted erosions of the oral and nasal cavities and conjunctivae. Cutaneous examination showed buccal erosions with limited mouth opening, entropion of the lower eyelids, trichiasis, cicatricial cornea, synechia of the nasal cavities and hypopigmented lesions of the abdomen. There were no anal or genital lesions. Cicatricial pemphigoid was confirmed by positive direct and indirect immunofluorescence on mucous biopsy. Systemic corticosteroids (2 mg/kg/day), maintained for 12 months, had led to complete healing of lesions. But due to cicatrization, synechia of the nasal cavities and corneal opacities, leading to a dramatic visual loss, have occurred. Dapsone 25 mg/day and topical ocular cyclosporine are now maintained to avoid relapse. Our review of the literature of all cases of CP showed that ocular and to a less degree, vulvar lesions are the most severe ones, due to the serious complications with scar formation.


Assuntos
Opacidade da Córnea/diagnóstico , Penfigoide Mucomembranoso Benigno/diagnóstico , Adolescente , Corticosteroides/uso terapêutico , Cegueira/prevenção & controle , Criança , Pré-Escolar , Doença Crônica , Opacidade da Córnea/tratamento farmacológico , Opacidade da Córnea/prevenção & controle , Ciclosporina/uso terapêutico , Dapsona/uso terapêutico , Entrópio/complicações , Entrópio/patologia , Feminino , Humanos , Hipopigmentação/diagnóstico , Hipopigmentação/tratamento farmacológico , Imunossupressores/uso terapêutico , Lactente , Masculino , Penfigoide Mucomembranoso Benigno/complicações , Penfigoide Mucomembranoso Benigno/tratamento farmacológico
11.
Skinmed ; 8(4): 240-1, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21137614

RESUMO

A 46-year-old woman with a medical history of chronic juvenile arthritis with bilateral prosthetic hips presented with vulvoperineal ulcerations of 3 years' duration. There was no diarrhea or recent weight loss. Cutaneous examination showed asymmetrical vulvar edema of the labia minora and labia majora with deep and linear ulcerations having verrucous borders located on the inguinocrural regions and the buttocks fold (Figure 1). On physical examination there was bilateral limited mobilization of the hips. A biopsy specimen was taken from the border of the vulvar ulceration and histologic examination showed under a hyperplasic epidermis an epithelioid granuloma with multinucleated giant cells of the dermis without caseification. Laboratory analyses and results from chest x-ray were normal. Results for Koch bacilla in the spittle, microbiologic studies (staining for microorganisms and cultures), and tuberculin intradermoreaction were negative. There was no Crohn's disease aspect on colonoscopy, and there was normal small bowel enterography. Systematic intestinal biopsies were also with normal aspect. Based on the clinical data and granulomatous histologic characteristics, the diagnosis of metastatic Crohn's disease without digestive involvement was obtained. The patient was started on metronidazole 1 g/d. After 6 months of treatment, there was an almost-complete healing of ulcerations (Figure 2). Treatment was well-tolerated.


Assuntos
Doença de Crohn/complicações , Metronidazol/uso terapêutico , Doenças da Vulva/tratamento farmacológico , Anti-Infecciosos/uso terapêutico , Doença de Crohn/diagnóstico , Feminino , Granuloma/etiologia , Granuloma/patologia , Humanos , Pessoa de Meia-Idade , Períneo/patologia , Resultado do Tratamento , Doenças da Vulva/diagnóstico , Doenças da Vulva/etiologia
12.
Dermatol Online J ; 16(1): 2, 2010 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-20137744

RESUMO

BACKGROUND: Linear IgA bullous dermatosis (LAD) of children is relatively frequent in Africa. We undertook this study to evaluate the frequency of this disease among autoimmune bullous diseases (AIBD) in Tunisian children. METHODS: We present a 32-year retrospective study (January 1976 to December 2007). Children with chronic acquired bullous diseases seen at the Charles Nicolle Hospital of Tunis and for whom direct immunofluorescence (DIF) of the perilesional skin demonstrated linear IgA immunoglobulin deposits were included in the study population. RESULTS: Thirty-one children with LAD were collected representing 65.9 percent of all AIBD of children collected in the same period, with a mean age of 5.5 years and a sex ratio M/F of 2.4. Most of the children had a generalized eruption (28/31) but more profuse on the face, pelvic region, buttocks, and limbs. Mucosal lesions were present in only 4 children (12.9%). The mean duration of the disease was 14 months. Direct immunofluorescence demonstrated predominantly linear IgA deposits along the dermal-epidermal junction in all patients. Faint IgG, IgM, and complement were also seen (20/31). Indirect immunofluorescence was negative in 67 percent of cases. Eight patients responded to Dapsone, but prednisone had to be added in 7 children and erythromycin in 4 others to control the disease. A long term remission period (34 months) was achieved in 61.9 percent of patients. CONCLUSION: This study confirms that LAD is the most common AIBD in children in Tunisia and it frequently occurs in preschool-aged males. Independently of the medication chosen for treatment, a long term remission is frequently observed.


Assuntos
Doenças Autoimunes/epidemiologia , Imunoglobulina A/análise , Dermatopatias Vesiculobolhosas/epidemiologia , Adolescente , Doenças Autoimunes/classificação , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/imunologia , Doenças Autoimunes/patologia , Criança , Pré-Escolar , Ativação do Complemento , Dapsona/administração & dosagem , Dapsona/uso terapêutico , Eritromicina/administração & dosagem , Eritromicina/uso terapêutico , Feminino , Técnica Direta de Fluorescência para Anticorpo , Humanos , Lactente , Masculino , Prednisona/administração & dosagem , Prednisona/uso terapêutico , Indução de Remissão , Estudos Retrospectivos , Dermatopatias Vesiculobolhosas/classificação , Dermatopatias Vesiculobolhosas/tratamento farmacológico , Dermatopatias Vesiculobolhosas/imunologia , Dermatopatias Vesiculobolhosas/patologia , Tunísia/epidemiologia
13.
Dermatol Online J ; 16(10): 16, 2010 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-21062610

RESUMO

Keratoacanthoma centrifugum marginatum (KCM) is a rare variant of keratoacanthoma characterized by a progressive peripheral growth with concomitant central healing. We report here a case of multiple KCM of the lower legs in a 48-year-old man. The lesions had progressively evolved over 3 years. They were multiple asymptomatic and confluent annular plaques of 5 to 20 cm, having papulo-nodular with hyperkeratotic and crusted borders and cicatricial center. Within the centers were numerous firm and pigmented minipapules of 1 to 2 mm. The typical clinical aspect, together with characteristic histological features confirmed the diagnosis of KCM. Herein we will highlight the clinical and histological features of KCM, as well as the different effective treatments. We will also briefly discuss KCM among the other types of keratoacanthomas.


Assuntos
Ceratoacantoma/patologia , Dermatoses da Perna/patologia , Administração Cutânea , Humanos , Ceratoacantoma/tratamento farmacológico , Dermatoses da Perna/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Tretinoína/uso terapêutico
14.
Dermatol Online J ; 16(3): 1, 2010 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-20233558

RESUMO

Peeling skin syndrome (PSS) is a rare form of ichthyosis with a probable autosomal recessive inheritance that exhibits superficial, painless, continual, or seasonal cutaneous exfoliation. The syndrome generally appears at birth or in infancy. We report a case of generalized PSS and provide a literature review. A 34-year-old woman reported a lifelong history of generalized and painless peeling of the skin that worsened in summer. Her parents were third degree cousins. Her twin sister and her two cousins presented with the same condition. Physical examination showed widespread superficial sheets of variable size that could be easily removed without bleeding or pain. No underlying erythema was noted. Otherwise, the patient was in good health. Histological findings showed an epidermal cleavage within the stratum corneum. The generalized form of PSS is classified into 3 types, A, B, and C, according to the classification system of Traupe and Mevorah. We have tried to classify the cases of generalized PSS already reported in the literature into one of these three types. Thirteen reported cases probably presented PSS-type A. Sixteen patients are best described as PSS-type B. Two patients exhibit PSS-type C. Fifteen reported patients had an acral form of peeling skin syndrome. The classification of the eleven remaining patients was difficult to determine. Our patient presented clinical and histological features of generalized PSS-type A.


Assuntos
Ictiose/classificação , Ictiose/patologia , Adulto , Consanguinidade , Feminino , Humanos , Ictiose/genética , Síndrome , Transglutaminases/genética
15.
Tunis Med ; 88(7): 519-22, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20582892

RESUMO

BACKGROUND: Cutaneous aspergillosis is rarely reported in diabetic patients. AIM: The objective of our study is to report a case of lethal disseminated aspergillosis revealed by multiples skin necroses, with pulmonary and sinusal involvement in a diabetic patient. CASE REPORT: A 60-year-old diabetic woman, presented with one month -rapidly -extensive, 1 to 10 cm skin necroses of the trunk, limbs and eyelids. Few days after her admission, she developed dyspnoea. Chest X-ray showed an interstitial and alveolar syndrome with multiple excavated anfractuous-edged-opacities. Facial CT scan showed a right orbital cellulitis with Pansinusitis. The methaminesilver stains on a cutaneous biopsy showed filamentous septate fungal hyphae with branches at right angles. The immunofluorescence with an anti-aspergillus serum was positive. The diagnosis of secondary disseminated aspergillosis to a primary pulmonary focus with cutaneous, sinusal, and upper airway's dissemination was made. The patient died despite an intravenous amphotericin B therapy. CONCLUSION: This report emphasizes the importance of evoking and seeking for a mycosis in every skin necrotic and ulcerative lesions occurring in an immunocompromised patient. The prognosis depends on the diagnosis and treatment institution delay.


Assuntos
Aspergilose/diagnóstico , Dermatomicoses/diagnóstico , Complicações do Diabetes/diagnóstico , Complicações do Diabetes/microbiologia , Aspergilose Pulmonar/diagnóstico , Sinusite/diagnóstico , Sinusite/microbiologia , Evolução Fatal , Feminino , Humanos , Pessoa de Meia-Idade
16.
Tunis Med ; 88(1): 9-11, 2010 Jan.
Artigo em Francês | MEDLINE | ID: mdl-20415206

RESUMO

BACKGROUND: Leishmaniasis is wide spread parasitic disease considered to be endemic in 88 countries in both old and new world. The standard treatment remains Meglumine antimoniate. AIM: We study the side effects of systemic meglumine antimoniate in cutaneous leishmaniasis. METHODS: We conduct a retrospective study covering 3-year period (2002- 2005). All medical reports of cutaneous leishmaniasis treated by systemic Meglumine antimoniate are reviewed. RESULTS: The study comprise 63 patients all treated by systemic meglumine antimoniate at the dose of 60 mg/kg/day for 10-15 days. Side effects were noted in 15 cases (12 females and 3 males). The subject's age range from 11 to 78 years. Stibio-intolerance (fever, rash, arthralgia, abdominal pain) was observed in 12 cases and stibiotoxicity in 3 cases: precordialgies 1 case, hyperamylasemia and increase liver enzyme: 1 case, pancytopenia, renal and hepatic failure leading to death: 1 case, skin eruption: 7 cases, pruritus and erythema in the site of injection: 5 cases, urticaria: 1 case. Meglumine antimoniate was stopped in 13 cases. CONCLUSION: Meglumine antimoniate is the generally recommended treatment of cutaneous leishmaniasis. In spite of the rarity of Glucantime's side effects, we recommend a careful survey especially in older patients.


Assuntos
Antiprotozoários/efeitos adversos , Leishmaniose Cutânea/tratamento farmacológico , Meglumina/efeitos adversos , Compostos Organometálicos/efeitos adversos , Adolescente , Adulto , Idoso , Animais , Antiprotozoários/administração & dosagem , Criança , Relação Dose-Resposta a Droga , Feminino , Humanos , Injeções Intramusculares/efeitos adversos , Masculino , Meglumina/administração & dosagem , Antimoniato de Meglumina , Pessoa de Meia-Idade , Compostos Organometálicos/administração & dosagem , Estudos Retrospectivos , Resultado do Tratamento
17.
Tunis Med ; 88(8): 597-601, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20711968

RESUMO

BACKGROUND: Rosacea is a common, chronic facial dermatosis of uncertain etiology, several well-defined types and variable progression. There is a paucity of epidemiologic studies from North African countries especially in Tunisia. AIM: to determine epidemiological, clinical, histological features, treatment and outcome of rosacea in a Tunisian study. METHODS: A retrospective study of all rosacea cases diagnosed in the outpatient Dermatology Department of Charles Nicolle hospital of Tunis was conducted between 1990, January and 2003, May. RESULTS: Our study included 244 patients. The diagnosis of rosacea was made on symptoms and clinical features in 185 cases and on histological findings in 59 patients. The hospital prevalence of rosacea was 0.2%. The sex ratio M/F was 0,4. Patient's Mean age was of 49 years. Triggered factors mentioned included most often: sun exposure (64%) and thermal stimuli (25%). Mean duration between the onset of symptoms and the first consultation was about 20 months. The rosacea subtypes were: erythematotelangiectatic type (12%), papulopustular rosacea (69%), and rhinophyma (3.7%). Granulomatous rosacea was diagnosed in 8 patients and steroid rosacea in 28 cases. Ocular rosacea was observed in 41 cases. Treatment modalities included: topical treatment (1.6%), systemic treatment (85%), systemic and topical treatment (5%) and surgical procedures (1.2%). CONCLUSIONS: Rosacea seems to be a frequent dermatosis in Tunisia where most of the population is phenotype IV-V. It affects mostly middle-aged women. Most of our patients present with papulopustular rosacea (69%). More epidemiological and clinical studies in North African countries should be conducted to emphasize these results.


Assuntos
Rosácea/epidemiologia , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fenótipo , Estudos Retrospectivos , Fatores de Risco , Rosácea/classificação , Rosácea/genética , Rosácea/cirurgia , Rosácea/terapia , Fatores Sexuais , Fatores de Tempo , Tunísia/epidemiologia
18.
Tunis Med ; 88(10): 742-5, 2010 Oct.
Artigo em Francês | MEDLINE | ID: mdl-20890823

RESUMO

BACKGROUND: Chronic lupus erythematosus is a cutaneous form of lupus erythematosus, usually involving photoexposed areas. AIM: The aim of our study is to evaluate the epidemio-clinical trends, therapeutic features and outcome of patients with chronic lupus erythematosus, through a Tunisian hospital series. We have tried to compare our results with those of other African and western series. METHODS: It is a retrospective study, concerning all patients with chronic lupus erythematosus, attending the Dermatology department of Charles Nicolle Hospital over an 11 years period. The patients' age, sex, clinical features, explorations results, treatment and evolution were recorded. RESULTS: A total of 104 patients were included. Chronic lupus erythematosus represented 0,1 % of all the dermatitis seen over 11 years. Chronic lupus erythematosus affects young women with a ratio F/M of 1,97 and an average age of 42 years. The discoid form was the most frequent clinical shape, observed in 73 % of cases (76 patients). The face was the most frequent localization of the lesions (91%). Five patients (4.8%) presented a generalized chronic lupus erythematosus. The direct immunofluorescence in sick skin was positive in 54 % of cases. Treatment included sun avoidance and oral antimalarials drugs in the majority of cases (95%). The progression from chronic lupus erythematosus to systemic lupus erythemetosus was observed in two cases (2%). CONCLUSION: Chronic lupus erythematosus is a relatively rare disorder in Tunisia, compared to other African countries, where prevalence is 7 to 10 times more frequent. As shown in our study, the most common clinical feature is the discoid form. The diagnosis can be confirmed by histopathological and direct immunofluorescence examination. Progression of chronic lupus erythematosus to systemic lupus erythematosus is possible, as observed in two of our patients. Thus, Patients with chronic lupus erythematosus should be continually followed up.


Assuntos
Lúpus Eritematoso Discoide/epidemiologia , Adolescente , Adulto , Idoso , Criança , Feminino , Humanos , Lúpus Eritematoso Discoide/terapia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Tunísia , Adulto Jovem
19.
Therapie ; 64(6): 389-94, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20025842

RESUMO

BACKGROUND: PUVA therapy and narrowband UVB therapy (NBUVB) constitute a widely used first line therapy in mycosis fungoides (MF). METHODS: It is a retrospective study dealing with 7 patients with MF treated by phototherapy [3 with PUVA (III, IV, V phototype) and 4 with NBUVB (III-IV phototype)]. One patient had both treatments (PUVA then NBUVB for a relapse). RESULTS: Complete response (CR) was achieved in 2 of the 3 patients treated with PUVA (they had stage IB-MF). Both had relapsed after 40 sessions and 7 months later, respectively. Relapses were treated by PUVA maintenance treatment (2 sessions/2 weeks) and NBUVB leading to CR. The third patient (stage IIA) did not respond to PUVA. CR was obtained in the 5 patients treated with NBUVB (stage IA-IB), after a mean cumulative dose of 58.3 J/cm(2). No relapse was noted with NBUVB after a mean follow-up period of 13.2 months (extremes: 2 -31 months). CONCLUSION: NBUVB is only effective on non-infiltrated plaques independently of phototype. PUVA therapy is effective even on infiltrated plaques. Both treatments do not prevent relapses.


Assuntos
Micose Fungoide/tratamento farmacológico , Micose Fungoide/radioterapia , Terapia PUVA , Terapia Ultravioleta , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Tunísia
20.
Tunis Med ; 87(10): 690-2, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20187359

RESUMO

BACKGROUND: Cryotherapy with liquid nitrogen is the most widely used method to treat hand and feet warts. Therapeutic response to this method depends on many factors related to warts and to the patient. The aim of this study is to determine factors influencing therapeutic response of warts to cryotherapy by liquid nitrogen. METHODS: It was a prospective transversal study including 100 patients with warts of the hands and/or feet treated by cryotherapy with liquid nitrogen (cotton wool bud) and referred to Dermatology Department of Charles Nicolle Hospital of Tunis. Demographic data, so as characteristics of warts were recorded. Patients received one treatment/week with a maximum of 4 sessions. Patients whose warts were seen to be resolved were classified as cured. Cure-predictive factors were studied with a multi varied study with logistic regression. RESULTS: Of the 100 patients (56 females/44 males, Mean age: 22 years), ten were withdrawn. In 89 patients, warts were present on hands, whereas 23 had warts on feet and 12 had warts on both hands and feet. The mean number of warts per patient was 7. The total cure rate was of 64.4% and was more elevated in hands compared to feet (70.8% versus 10.5%). There was no difference between mean ages of cured group and not cured one (22.2 years versus 21 years). The mean duration of warts in cured patients was lower than that of not cured patients. The mean number of warts before treatment was 4.3 in cured patients and 12.3 warts in not cured patients. The mean number of treatments was 2.3 in cured patients and 4 treatments in not cured patients. The difference between these factors into cured and not cured groups was statistically significant in uni-varied study but not significant in multi-varied one. CONCLUSION: The effectiveness of liquid nitrogen used by traditional method in the treatment of hand and feet warts seems to depend on multiple factors: wart's duration, number of warts and number of treatments. These factors depend on each other.


Assuntos
Criocirurgia/métodos , Pé/cirurgia , Mãos/cirurgia , Nitrogênio/administração & dosagem , Verrugas/cirurgia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Estudos Transversais , Feminino , Pé/virologia , Mãos/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA